Mr Daniel Vulkan, BA MScStatisticianEmail: d.vulkan@qmul.ac.ukTelephone: Te;l: +44 (0)20 7882 3526ProfilePublicationsProfileI joined the Wolfson Institute in 2016, after completely MSc in Social Research Methods from the London School of Economics & Political Science in 2014. I have also previously worked as an actuary and as a demographic researcher. I am a statistician in the Centre for Prevention, Detection and Diagnosis. I am also a part of the NIHR Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis.ResearchPublicationsLung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis (The Lancet Regional Health – Europe, 2021) Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial (British Journal of General Practice, 2021) First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer (British Journal of Cancer, 2020) Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial (The Lancet Oncology, 2020) Duffy SW, Seedat F, Kearins O et al. (2022). The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. nameOfConference DOI: 10.1038/s41416-022-01714-9 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77784 Duffy SW, Hudson S, Vulkan D et al. (2022). Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?. nameOfConference DOI: 10.1177/09691413211066476 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77785 Field JK, Vulkan D, Davies MPA et al. (2021). Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. nameOfConference DOI: 10.1016/j.lanepe.2021.100179 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75621 Field J, Vulkan D, Davies M et al. (2021). OA19.02 The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis. nameOfConference DOI: 10.1016/j.jtho.2021.08.098 QMRO: qmroHref Laake JP, Vulkan D, Quaife SL et al. (2021). Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial. nameOfConference DOI: 10.3399/bjgp20X713489 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71602 Kaushal A, Hirst Y, Tookey S et al. (2020). Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population. nameOfConference DOI: 10.1016/j.ypmed.2020.106268 QMRO: qmroHref Field JK, Vulkan D, Davies MPA et al. (2020). Liverpool lung project lung cancer risk stratification model: Calibration and prospective validation. nameOfConference DOI: 10.1136/thoraxjnl-2020-215158 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68653 Duffy S, Vulkan D, Cuckle H et al. (2020). Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: Long-term follow-up of the uk age rct. nameOfConference DOI: 10.3310/hta24550 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68564 Duffy SW, Vulkan D, Cuckle H et al. (2020). Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. nameOfConference DOI: 10.1016/S1470-2045(20)30398-3 QMRO: qmroHref Chapman D, Poirier V, Vulkan D et al. (2020). First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer.. nameOfConference DOI: 10.1038/s41416-020-0947-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67124 Ghimire B, Maroni R, Vulkan D et al. (2020). Erratum to “Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme” (Lung Cancer (2019) 134 (66–71), (S0169500219304702), (10.1016/j.lungcan.2019.05.026)). nameOfConference DOI: 10.1016/j.lungcan.2019.10.007 QMRO: qmroHref Ghimire B, Maroni R, Vulkan D et al. (2019). Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme. nameOfConference DOI: 10.1016/j.lungcan.2019.05.026 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58971 Aarts AMWM, Duffy SW, Geurts SME et al. (2019). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. nameOfConference DOI: 10.1016/j.breast.2019.03.003 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64452 von Wagner C, Hirst Y, Tookey S et al. (2018). Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.. nameOfConference DOI: 10.1136/bmjopen-2018-022263 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/39448 Burnside ES, Vulkan D, Blanks RG et al. (2018). Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.. nameOfConference DOI: 10.1148/radiol.2018171539 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58642 Aarts AMWM, Duffy SW, Geurts SME et al. (2018). Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands). nameOfConference DOI: 10.1177/0969141318814869 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54759 Benton SC, Butler P, Allen K et al. (2017). GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.. nameOfConference DOI: 10.1038/bjc.2017.129 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/33423